The Brief Introduction to Sitagliptin Phosphate

Sitagliptin phosphate is a medication used to treat type 2 diabetes mellitus. It is sold under the brand name Januvia and works by inhibiting an enzyme called dipeptidyl peptidase-4 (DPP-4), which increases the production of insulin by the pancreas and decreases the amount of glucose produced by the liver.  Sitagliptin phosphate is typically taken once daily with or without food, and the dosage may vary depending on the patient's individual needs and response to the medication. It may be used alone or in combination with other diabetes medications. As with all medications, sitagliptin phosphate may cause side effects, including headache, upper respiratory tract infection, and stomach pain. In rare cases, it may also cause more serious side effects, such as pancreatitis or severe joint pain. It is important to discuss any potential side effects with a healthcare provider before starting this medication.

Sandoo Pharmaceuticals and Chemcials Co.,Ltd., established in 2009, is located in No 98 chuangyuan Rd,Hi-tech zone,Ningbo,Zhejiang Province.  We have formed supply capacity from R&D, pilot to commercial scale., including API, anti-cancer, antiviral drug intermediates, fine chemicals, food additives, and key intermediates of polypeptide compounds in the forefront of biopharmaceuticals in the world. Our cooperated R&D centers are located in Shanghai, Beijing, Guangzhou, Hangzhou, covering new drugs and advanced compounds. The R&D centers have strong R&D and innovation capabilities in process development, process optimization and analytical method development.